AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Evogene Ltd. announced that CEO Ofer Haviv will present at the H.C. Wainwright 27th Annual Global Investment Conference in New York on September 8-10, 2025. Haviv will highlight the company's new strategic focus on maximizing the value of ChemPass AI, a generative AI tech-engine for small molecule discovery and optimization in pharmaceuticals and agriculture. The presentation is scheduled for September 10, 2025, at 1:00 PM ET, and Haviv will be available for one-on-one meetings.
Evogene Ltd. (NASDAQ: EVGN) has announced that CEO Ofer Haviv will present at the H.C. Wainwright 27th Annual Global Investment Conference in New York from September 8-10, 2025. Haviv's presentation, scheduled for September 10, 2025, at 1:00 PM ET, will focus on the company's strategic shift towards maximizing the value of ChemPass AI, a proprietary generative AI tech-engine for small molecule discovery and optimization in pharmaceuticals and agriculture [1][2].Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet